To support the link between SLC6A20 expression and COVID-19, the canSAR data set, providing informationabout the immune landscape of pan-cancer tumors, was utilized.28 This analysis demonstrated the association ofincreased SLC6A20 expression with interferon-λ(IFN-λ), an immune related marker, and the inflammation signatureparticularly in THYM, READ, COAD, ESCA, and OV samples (Figure 5C). Here, SLC6A20 is linked to cancer.